All the events here are relevant to people working in dementia research. If you would like to add your own you can submit an event
- This event has passed.
Neuroimmunology Drug Development Summit
March 25 - March 27
As large pharma companies turn to prioritize their R&D investments into neuroscience and capitalize on the CNS momentum, it is an exciting time for neuroimmunology drug discovery.
With advances in understanding neurological pathophysiology, leveraging patient data, and using single-cell technologies to understand spatial and temporal microglia heterogeneity, neuroimmunology targets, including TREM2, RIPK1, ferroptosis, and beyond are hotter than ever to develop neuroinflammatory-targeted therapeutics against neurodegenerative diseases like Alzheimer’s, Parkinson’s, ALS, MS, and beyond.
Despite ongoing innovation in the space, significant translational hurdles still remain to see the breakthrough clinical success of neuroimmunology modulators, namely a lack of disease-relevant neuroinflammatory biomarkers to correlate with clinical outcomes to de-risk lengthy and expensive neurodegenerative clinical trials.
Uniting 100+ CNS scientists, directors, and lab heads from Sanofi, Vigil Neuroscience, Roche, Alector, Biogen, BMS, and Muna Therapeutics, the 6th Neuroimmunology Drug Development Summit is biopharma’s must-attend forum to learn, benchmark, and debate cutting-edge mechanistic insights into glial biology, innovation and applications of iPSC-derived cells and brain organoids, and leverage patient data and TREM2 clinical learnings to optimize neuroimmunology translation and develop transformative therapeutics for neurological disorders.
